REM sleep behavior disorder and dementia: Cognitive differences when compared with AD

Neurology

Volumn 52, Issue 5, 1999, Pages 951-957

  Ferman, Tanis J ^a,b   Boeve, B F ^a   Smith, G E ^a   Silber, M H ^a   Kokmen, E ^a   Petersen, R C ^a   Ivnik, R J ^a  

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COGNITION; DEMENTIA; DISEASE SEVERITY; HUMAN; LEWY BODY; POLYSOMNOGRAPHY; PRIORITY JOURNAL; REM SLEEP; SLEEP DISORDER;

EID: 0033596841     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.52.5.951     Document Type: Article

References (55)

1. American Sleep Disorders Association. The international classification of sleep disorders diagnostic and coding manual. Rochester, MN: American Sleep Disorders Association, 1997.
2. Hendricks JC, Morrison AR, Mann GL. Different behaviors during paradoxical sleep without atonia depend on pontine lesion site. Brain Res 1982;239:81-105.
3. Jouvet M, Delorme F. Locus coeruleus et sommeil paradoxal. CR Seances Soc Biol 1965;159:895-899.
4. Cornella CL, Tanner CM, Ristanovic RK. Polysomnographic sleep measures in Parkinson's disease patients with treatment-induced hallucinations. Ann Neurol 1993;34:710-714.
5. Tachibana N, Kimura K, Kitajima K, Shinde A, Kimura J, Shibasaki H. REM sleep without atonia at early stage of sporadic olivopontocerebellar atrophy. J Neurol Sci 1995;132: 28-34.
6. Tan A, Salgado M, Farm S. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa. Mov Disord 1996;11:214-216.
7. Turner RS, Chervin RD, Frey KA, Minoshima S, Kuhl DE. Probable diffuse Lewy body disease presenting as REM sleep behavior disorder. Neurology 1997;49:523-527.
8. Plazzi G, Corsini R, Provini F, et al. REM sleep behavior disorders in multiple system atrophy. Neurology 1997;48: 1094-1097.
9. Schenck C, Bundlie S, Mahowald M. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder. Neurology 1996;46:388-393.
10. Uchiyama M, Isse K, Tanaka K, et al. Incidental Lewy body disease in a patient with REM sleep behavior disorder. Neurology 1995;45:709-712.
11. Boeve BF, Silber MH, Ferman TJ, et al. REM sleep behavior disorder and degenerative dementia: an association likely refleeting Lewy body disease. Neurology 1998;51:363-370.
12. McKeith I, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the Consortium on DLB International Workshop. Neurology 1996;47:1113-1124.
13. Galasko D, Katzman R, Salmon D, Hansen L. Clinical and neuropathological findings in Lewy body dementias. Brain Cogn 1996;31:166-175.
14. Gibb WRG, Esiri MM, Lees AJ. Clinical and pathological features of diffuse cortical Lewy body disease (Lewy body dementia). Brain 1985;110:1131-1153.
15. Hansen LA, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 1990;40:1-8.
16. Lennox G, Lowe J, Landon M, Byrne E, Mayer R, Godwin-Austen R. Diffuse Lewy body disease: correlative neuropathology using anti-ubiquitin immunocytochemistry. J Neurol Neurosurg Psychiatry 1989;52:1236-1247.
17. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 3rd ed. Rev. Washington, DC: American Psychiatric Association, 1987.
18. Reisberg B, Ferris S, deLeon M, Crook T. Global Deterioration Scale (GDS). Psychopharmacol Bull 1988;24:661-662.
19. Reisberg B, Schneider L, Doody R, et al. Clinical global measures of dementia. Position paper from the International Working Group on Harmonization of Dementia Drug Guidelines. Alzheimer Dis Assoc Disord 1997;11(suppl 3):8-18.
20. Rechtschaffen A, Kales A. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects. Los Angeles: Brain Information Service, Brain Research Institute, 1968.
21. Petersen RC, Kokmen E, Tangalos EG, Ivnik RJ, Kurland LT. Mayo Clinic Alzheimer's Disease Patient Registry. Aging 1990;2:408-415.
22. Dickson D, Davies P, Mayeux R, et al. Diffuse Lewy body disease. Neuropathological and biochemical studies of six patients. Acta Neuropathol 1987;75:8-15.
23. Kosaka K, Yoshimura M, Ikeda K, et al. Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of various degree - a new disease? Clin Neuropathol 1984;3:185-192.
24. Smith GE, Ivnik RJ, Malec JF, Petersen RC, Kokmen R, Tangalos E. Mayo cognitive factor scales: derivation of a short battery and norms for factor scores. Neuropsychology 1994;8: 194-202.
25. Wechsler D. Wechsler Adult Intelligence Scale-Revised. San Antonio, TX: The Psychological Corporation, 1981.
26. Wechsler D. Wechsler Memory Scale-Revised. San Antonio, TX: The Psychological Corporation, 1987.
27. Rey A. L'examen clinique en psychologie [The clinical examination in psychology]. Paris: Presses Universitaires de France, 1964.
28. Ivnik RJ, Malec JF, Smith GE, et al. Mayo's older Americans normative studies: WMS-R norms for ages 56 to 94. Clin Neuropsychol 1992;6(suppl):49-82.
29. Malec JF, Ivnik RJ, Smith GE. Neuropsychology and normal aging: the clinician's perspective. In: Parks R, Zee R, Wilson R, eds. Neuropsychology of Alzheimer's disease and other dementias. New York: Oxford University Press, 1993:81-111.
30. Ivnik RJ, Malec JF, Smith GE, Tangalos EG, Petersen RC. Neuropsychological tests' norms above age 55: COWAT, BNT, MAE token, WRAT-R reading, AMNART, Stroop, TMT, and JLO. Clin Neuropsychol 1996;10:262-278.
31. Kaplan EF, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1978.
32. Benton AL, Hamsher K. Multilingual aphasia examination manual. Iowa City: University of Iowa, 1978.
33. Salmon DP, Galasko D, Hansen LA, et al. Neuropsychological deficits associated with diffuse Lewy body disease. Brain Cogn 1996;31:148-165.
34. Gnanalingham K, Byrne E, Thornton A, Sambrook M, Bannister P. Motor and cognitive function in Lewy body dementia: comparison with Alzheimer's and Parkinson's diseases. J Neurol Neurosurg Psychiatry 1997;62:243-252.
35. Bondi MW, Kaszniak AW, Bayles KA, Vance KT. Contributions of frontal system dysfunction to memory and perceptual abilities in Parkinson's disease. Neuropsychology 1993;7:89-102.
36. Brown R, Marsden C. Visuospatial function in Parkinson's disease. Brain 1986;109:987-1002.
37. Cooper J, Sagar H, Jordan N, Harvey N, Sullivan E. Cognitive impairment in early, untreated Parkinson's disease and it's relationship to motor disability. Brain 1991;114:2095-2122.
38. Smith GE, Malec JF, Ivnik RJ. Validity of the construct of nonverbal memory: a factor analytic study in a normal elderly sample. J Clin Exp Neuropsychol 1992;14:211-221.
39. Schenck CH, Mahowald MW. REM sleep parasomnias. Neurol Clin 1996;14:697-720.
40. Galasko D, Hansen LA, Katzman R, Salmon DP, Hansen L. Clinical-neuropathological correlations in Alzheimer's disease and related disorders. Arch Neurol 1994;51:888-895.
41. Ala T, Yang K, Sung J, Frey W. Hallucinations and signs of parkinsonism help distinguish patients with dementia and cortical Lewy bodies from patients with Alzheimer's disease at presentation: a clinicopathological study. J Neurol Neurosurg Psychiatry 1997;62:16-21.
42. Cercy SP, Bylsma FW. Lewy bodies and progressive dementia: a critical review and meta-analysis. JINS 1997;3:179-194.
43. Mayeux R, Denaro J, Hemenegildo N, et al. A population-based investigation of Parkinson's disease with and without dementia: relationship to age and gender. Arch Neurol 1992; 49:492-497.
44. Lippa C, Smith T, Swearer JM. Alzheimer's disease and Lewy body disease: a comparative clinicopathological study. Ann Neurol 1994;35:81-88.
45. Byrne E, Lennox G, Lowe J, Godwin-Austin R. Diffuse Lewy body disease: clinical features in 15 cases. J Neurol Neurosurg Psychiatry 1989;52:709-717.
46. Olichney JM, Galasko D, Salmon DP, et al. Cognitive decline is faster in Lewy body variant than in Alzheimer's disease. Neurology 1998;51:351-357.
47. Richards M, Stern Y, Marder K, Cote L, Mayeux R. Relationships between extrapyramidal signs and cognitive function in a community-dwelling cohort of patients with Parkinson's disease. Ann Neurol 1993;33:267-274.
48. Schenck CH, Mahowald MW, Anderson ML, Silber MH, Boeve BH, Parisi JE. Lewy body variant of Alzheimer's disease (AD) identified by postmortem ubiquitin staining in a previously reported case of AD associated with REM sleep behavior disorder. Biol Psychiatry 1997;42:527-528.
49. Perry E, Perry R. Acetylcholine and hallucinations: disease-related compared to drug-induced alterations in human consciousness. Brain Cogn 1995;28:240-258.
50. Perry E, Marshall E, Perry R, et al. Cholinergic and dopaminergic activities in senile dementia of the Lewy body type. Alzheimer Dis Assoc Disord 1990;4:87-95.
51. Samuel W, Galasko D, Masliah E, Hansen L. Neocortical Lewy body counts correlate with dementia in the Lewy body variant of Alzheimer's disease. J Neuropathol Exp Neurol 1996;55:44-52.
52. Vogt B, Finch D, Olson C. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cereb Cortex 1992;2:435-443.
53. Mishkin M, Ungerleider L, Macko K. Object vision and spatial vision: two cortical pathways. Trends Neurosci 1983:414-417.
54. Ettlinger G. Object visionand spatial vision: the neuropsychological evidence for the distinction. Cortex 1990;26:319-341.
55. Haxby J, Horwitz B, Ungerleider L, et al. The functional organization of human extrastriate cortex: a PET-rCBF study of selective attention to faces and locations. J Neurosci 1994;14: 6336-6353.